BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1918462)

  • 61. Neonatal lupus erythematosus. Report of serological and immunogenetic studies in twins discordant for congenital heart block.
    Watson RM; Scheel JN; Petri M; Kan JS; Provost TT; Ratrie H; Callan NA
    Br J Dermatol; 1994 Mar; 130(3):342-8. PubMed ID: 8148276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Histocompatibility antigens in discoid and systemic lupus erythematosus.
    Millard LG; Rowell NR; Rajah SM
    Br J Dermatol; 1977 Feb; 96(2):139-44. PubMed ID: 843448
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Taxane associated subacute cutaneous lupus erythematosus.
    Marchetti MA; Noland MM; Dillon PM; Greer KE
    Dermatol Online J; 2013 Aug; 19(8):19259. PubMed ID: 24021438
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients.
    Watanabe T; Tsuchida T
    Dermatology; 1995; 190(4):277-83. PubMed ID: 7655105
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy.
    Reed BR; Huff JC; Jones SK; Orton PW; Lee LA; Norris DA
    Ann Intern Med; 1985 Jul; 103(1):49-51. PubMed ID: 3873891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease.
    Harley JB; Sestak AL; Willis LG; Fu SM; Hansen JA; Reichlin M
    Arthritis Rheum; 1989 Jul; 32(7):826-36. PubMed ID: 2787639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relationship between circulating anti-Ro/SS-A antibody levels and skin disease activity in subacute cutaneous lupus erythematosus.
    Purcell SM; Lieu TS; Davis BM; Sontheimer RD
    Br J Dermatol; 1987 Sep; 117(3):277-87. PubMed ID: 3118930
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature.
    Watson RM; Lane AT; Barnett NK; Bias WB; Arnett FC; Provost TT
    Medicine (Baltimore); 1984 Nov; 63(6):362-78. PubMed ID: 6390081
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidemiological characteristics of patients with cutaneous lupus erythematosus.
    Avilés Izquierdo JA; Cano Martínez N; Lázaro Ochaita P
    Actas Dermosifiliogr; 2014; 105(1):69-73. PubMed ID: 24268922
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    Holtman JH; Neustadt DH; Klein J; Callen JP
    J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. A new subset of lupus with characteristic skin manifestations].
    Bardach H
    Hautarzt; 1982 Oct; 33(10):537-41. PubMed ID: 6984040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HLA antigens in systemic lupus erythematosus.
    Dostál C; Iványi D; Macurová H; Hána I; Strejcek J
    Ann Rheum Dis; 1977 Feb; 36(1):83-5. PubMed ID: 843116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Annular erythema. A comparative study of Sjögren syndrome with subacute cutaneous lupus erythematosus.
    Katayama I; Teramoto N; Arai H; Nishioka K; Nishiyama S
    Int J Dermatol; 1991 Sep; 30(9):635-9. PubMed ID: 1938076
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Subacute cutaneous lupus erythematosus associated with phenytoin.
    Ross S; Ormerod AD; Roberts C; Dwyer C; Herriot R
    Clin Exp Dermatol; 2002 Sep; 27(6):474-6. PubMed ID: 12372089
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathogenesis of cutaneous lupus erythematosus.
    Norris DA; Lee LA
    Clin Dermatol; 1985; 3(3):20-35. PubMed ID: 2463862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Subacute cutaneous lupus erythematosus induced by nifedipine.
    Gubinelli E; Cocuroccia B; Girolomoni G
    J Cutan Med Surg; 2003; 7(3):243-6. PubMed ID: 12574905
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Subacute cutaneous lupus erythematosus associated with chronic interstitial pneumonitis.
    Heymann WR; Manders SM; Gottlieb GJ; Agia GA; Sallizoni J
    Int J Dermatol; 1995 May; 34(5):354-6. PubMed ID: 7607798
    [No Abstract]   [Full Text] [Related]  

  • 80. Neonatal lupus erythematosus: a review of the racial differences and similarities in clinical, serological and immunogenetic features of Japanese versus Caucasian patients.
    Miyagawa S
    J Dermatol; 2005 Jul; 32(7):514-22. PubMed ID: 16335866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.